Skip to content Back to top
 

Return to FOI Requests

FOI2026/2066

Reference FOI2026/2066
Description GLP-1 weight management treatment
Date Requested 29/09/2026
Date Replied 28/10/2026
Category Prescribing

I am requesting the following information under the Freedom of Information Act 2000. This request relates to NHS Greater Manchester Integrated Care Board only.

  1. Does the ICB commission NHS weight management services involving GLP-1 medicines?

If yes, please provide details of the service(s) commissioned.

  1. How many patients in the ICB area have received NHS-funded GLP-1 medicines specifically for weight management (excluding type 2 diabetes)?

Please provide figures by financial year:

  • 2023/24
  • 2024/25
  • 2025/26
  • 2026 to date

Please provide figures by medicine where available.

If your ICB was formed or changed its boundary in April 2026, please include data for the predecessor ICB(s) covering your area.

  1. Yes – NHS GM commissions Tier 3 Specialist Weight Management Services as per table below. There are also two providers of Tier 3 Specialist Weight Management Services, (SWMS) who are able to prescribe GLP-1 semaglutide and liraglutide.

Details of the Tier 3 SWMS are listed below:

Locality Specialist Tier 3 Weight Management Services
Bolton Currently no commissioned provider however GPs can refer eligible patients via providers operating under Right to Choose.
Bury MoreLife as well as providers operating under Right to Choose.
Manchester Currently no commissioned provider however GPs can refer eligible patients via providers operating under Right to Choose
Oldham ABL Health as well as providers operating under Right to Choose.
Rochdale Northern Care Alliance who sub-contract to MoreLife

As well as providers operating under Right to Choose.
Salford MoreLife as well as providers operating under Right to Choose.
Stockport ABL Health as well as providers operating under Right to Choose.
Tameside MoreLife as well as providers operating under Right to Choose.
Trafford Manchester University Hospitals NHS Foundation Trust however do not prescribe.  For patients who require Specialist Tier 3 services with a medication pathway, GPs can refer to providers who are operating under Right to Choose.
Wigan Currently no commissioned provider however GPs can refer eligible patients via providers operating under Right to Choose.

GP practices can also offer tirzepatide under the national Quality & Outcomes Framework.

Prescribing of GLP-1 medication pathway for obesity and weight management must be in line with the NHS GM Commissioning Statement which is aligned to national policy. The commissioning statement can be found here https://gmmmg.nhs.uk/download/?file_id=10773

 

  1. NHS Greater Manchester does not hold the requested monthly figures for the number of patients initiated GLP-1s for weight management. Prescribing expenditure and the number of items dispensed can be monitored through ePACT; however, ePACT data do not distinguish between clinical indications. It is therefore not possible to identify from these data how many patients received a GLP-1 specifically for weight management.

Return to FOI Requests

Launch Recite Me assistive technology